Diabetes and radiocontrast media increase endothelin converting enzyme-1 in the kidney

Kidney International

Volumn 74, Issue 1, 2008, Pages 91-100

  Khamaisi, M ^a,f   Raz, I ^a   Shilo, V ^a   Shina, A ^a   Rosenberger, C ^b   Dahan, R ^a   Abassi, Z ^c   Meidan, R ^d   Lecht, S ^e   Heyman, S N ^a  

^a HEBREW UNIVERSITY   (Israel)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Contrast media; Diabetes; Hypoxia; Kidney; Rat

Indexed keywords

CONTRAST MEDIUM; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; GLUCOSE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DOSE KIDNEY FUNCTION RELATION; ENZYME BINDING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY MEDULLA; KIDNEY TUBULE ABSORPTION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

EID: 45249109079     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.112     Document Type: Article

References (67)

1. Palm F, Cederberg J, Hansell P et al. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003; 46: 1153-1160.
2. Ries M, Basseau F, Tyndal B et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging 2003; 171: 104-113.
3. Rosenberger C, Khamaisi M, Abassi Z et al. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int 2008; 73: 34-42.
4. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995; 332: 647-655.
5. Scherzer P, Nachliel I, Bar-On H et al. Renal Na-K-ATPase hyperactivity in diabetic Psammomys obesus is related to glomerular hyperfiltration but is insulin-independent. J Endocrinol 2000; 167: 347-354.
6. Palm F. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy. Clin Exp Pharmacol Physiol 2006; 33: 997-1001.
7. Leon CA, Raij L. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy. J Hypertens 2005; 23: 1931-1937.
8. Li B, Yao J, Kawamura K et al. Real-time observation of glomerular hemodynamic changes in diabetic rats: effects of insulin and ARB. Kidney Int 2004; 66: 1939-1948.
9. Klahr S, Morrissey J. -Arginine as a therapeutic tool in kidney disease. Semin Nephrol 2004; 24: 389-394.
10. Nishiyama A, Miyatake A, Aki Y et al. Adenosine A(1) receptor antagonist KW-3902 prevents hypoxia-induced renal vasoconstriction. J Pharmacol Exp Ther 1999; 291: 988-993.
11. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
12. VanZee BE, Hoy WE, Talley TE et al. Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients. Ann Intern Med 1978; 89: 51-54.
13. Barshay ME, Kaye JH, Goldman R et al. Acute renal failure in diabetic patients after intravenous infusion pyelography. Clin Nephrol 1973; 1: 35-39.
14. Rudnick MR, Goldfarb S, Wexler L et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254-261.
15. McCullough PA, Wolyn R, Rocher LL et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375.
16. Heyman SN, Clark BA, Kaiser N et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992; 3: 58-65.
17. Rosenberger C, Heyman SN, Rosen S et al. Upregulation of HIF in acute renal failure: evidence for a protective transcriptional response to hypoxia. Kidney Int 2005; 67: 531-542.
18. Heyman SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 2008; 3: 288-296.
19. Khan ZA, Farhangkhoee H, Mahon JL et al. Endothelins: regulators of extracellular matrix protein production in diabetes. Exp Biol Med (Maywood) 2006; 231: 1022-1029.
20. Itoh Y, Nakai A, Kakizawa H et al. Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI(2) derivative. Horm Res 2001; 56: 165-171.
21. Kohan DE. The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure. Curr Opin Nephrol Hypertens 2006; 15: 34-40.
22. Oldroyd S, Slee SJ, Haylor J et al. Role for endothelin in the renal responses to radiocontrast media in the rat. Clin Sci (Lond) 1994; 87: 427-434.
23. Attina T, Camidge R, Newby DE et al. Endothelin antagonism in pulmonary hypertension, heart failure, and beyond. Heart 2005; 6: 825-831.
24. Davenport AP, Maguire JJ. Endothelin. Handb Exp Pharmacol 2006; 176(Part 1): 295-329.
25. B in the renal tissue of rats with compensated and decompensated heart failure. J Cardiovasc Pharmacol 2004; 44: S362-S365.
26. Goldfarb M, Rosenberger C, Abassi Z et al. Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance. Am J Nephrol 2006; 26: 22-33.
27. Keynan S, Khamaisi M, Dahan R et al. Increased expression of endothelin-converting enzyme-1c isoform in response to high glucose levels in endothelial cells. J Vasc Res 2004; 41: 131-140.
28. Xu D, Emoto N, Giaid A et al. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994; 78: 473-485.
29. Valdenaire O, Schweizer A. Endothelin-converting enzyme-like 1 (ECEL1; 'XCE'): a putative metallopeptidase crucially involved in the nervous control of respiration. Biochem Soc Trans 2000; 28: 426-430.
30. Schmidt M, Kroger B, Jacob E et al. Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett 1994; 356: 238-243.
31. Turner AJ, Barnes K, Schweizer A et al. Isoforms of endothelin-converting enzyme: why and where? Trends Pharmacol Sci 1998; 19: 483-486.
32. Itoh Y, Nakai A, Kakizawa H et al. Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI(2) derivative. Horm Res 2001; 56: 165-171.
33. Persson PB, Tepel M. Contrast medium-induced nephropathy: the pathophysiology. Kidney Int Suppl 2006; 100: S8-S10.
34. Muller L, Barret A, Etienne E et al. Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease. J Biol Chem 2003; 278: 545-555.
35. Bousette N, Giaid A. Endothelin-1 in atherosclerosis and other vasculopathies. Can J Physiol Pharmacol 2003; 81: 578-587.
36. Maguire JJ, Johnson CM, Mockridge JW et al. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol 1997; 122: 1647-1654.
37. Sawamura T, Shinmi O, Kishi N et al. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane. Biochim Biophys Acta 1993; 1161: 295-302.
38. Levy N, Gordin M, Smith MF et al. Hormonal regulation and cell-specific expression of endothelin-converting enzyme 1 isoforms in bovine ovarian endothelial and steroidogenic cells. Biol Reprod 2003; 68: 1361-1368.
39. Korth P, Bohle RM, Corvol P et al. Cellular distribution of endothelin-converting enzyme-1 in human tissues. J Histochem Cytochem 1999; 47: 447-462.
40. Vogel V, Backer A, Heller J et al. The renal endothelin system in the Prague hypertensive rat, a new model of spontaneous hypertension. Clin Sci (Lond) 1999; 97: 91-98.
41. Fattal I, Abassi Z, Ovcharenko E et al. Effect of dietary sodium intake on the expression of endothelin. Nephron Physiol 2004; 98: p89-p96.
42. Abassi Z, Winaver J, Rubinstein I et al. Renal endothelin-converting enzyme in rats with congestive heart failure. J Cardiovasc Pharmacol 1998; 31(Suppl 1): S31-S34.
43. Nakayama Y, Nonoguchi H, Kiyama S et al. Intranephron distribution and regulation of endothelin-converting enzyme-1 in cyclosporin A-induced acute renal failure in rats. J Am Soc Nephrol 1999; 10: 562-571.
44. Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006; 26: 232-244.
45. Persson B. Contrast-induced nephropathy. Eur Radiol 2005; 15(Suppl 4): D65-D69.
46. Clark BA, Kim D, Epstein FH. Endothelin and atrial natriuretic peptide levels following radiocontrast exposure in humans. Am J Kidney Dis 1997; 30: 82-86.
47. Sorokin A, Kohan DE. Physiology and pathology of endothelin-1 in renal mesangium. Am J Physiol Renal Physiol 2003; 285: F579-F589.
48. Liss P, Carlsson PO, Nygren A et al. ET-A receptor antagonist BQ123 prevents radiocontrast media-induced renal medullary hypoxia. Acta Radiol 2003; 44: 111-117.
49. Pollock DM, Polakowski JS, Wegner CD et al. Beneficial effect of ETA receptor blockade in a rat model of radiocontrast-induced nephropathy. Ren Fail 1997; 19: 753-761.
50. Takagi C, Bursell SE, Lin YW et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci 1996; 37: 2504-2518.
51. Cantley LG, Heyman SN, Epstein FH. Radiocontrast agents induce endothelin-1 mRNA in bovine endothelial cells. J Am Soc Nephrol 1991; 2: 660 (Abstract).
52. Kourembanas S, Marsden PA, McQuillan LP et al. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991; 88: 1054-1057.
53. Haase VH. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006; 291: F271-F281.
54. Masatsugu K, Itoh H, Chun TH et al. Shear stress attenuates endothelin and endothelin-converting enzyme expression through oxidative stress. Regul Pept 2003; 111: 13-19.
55. López-Ongil S, Senchak V, Saura M et al. Superoxide regulation of endothelin-converting enzyme. J Biol Chem 2000; 275: 26423-26427.
56. Heyman SN, Goldfarb M, Darmon D et al. Tissue oxygenation modifies nitric oxide bioavailability. Microcirculation 1999; 6: 199-203.
57. Pfab T, Thöne-Reineke C, Theilig F et al. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure. J Am Soc Nephrol 2006; 17: 1082-1089.
58. Wang A, Holcslaw T, Bashore TM et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 2000; 57: 1675-1680.
59. Heyman SN, Rosenberger C, Rosen S. Regional alterations in renal hemodynamics and oxygenation: a role in radiocontrast nephropathy. Nephrol Dial Transplant 2005; 20(Suppl 1): i6-i11.
60. Khamaisi M, Rudich A, Beeri I et al. Metabolic effects of gamma-linolenic acid-alpha-lipoic acid conjugate in streptozotocin diabetic rats. Antioxid Redox Signal 1999; 1: 523-535.
61. Waxman L, Doshi KP, Gaul SL et al. Identification and characterization of endothelin converting activity from EAHY 926 cells: evidence for the physiologically relevant human enzyme. Arch Biochem Biophys 1994; 308: 240-253.
62. Santaniello A, Salazar G, Lenna S et al. HLA-B35 upregulates the production of endothelin-1 in HLA-transfected cells: a possible pathogenetic role in pulmonary hypertension. Tissue Antigens 2006; 68: 239-244.
63. Tabakman R, Lazarovici P, Kohen R. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J Neurosci Res 2002; 68: 463-469.
64. Meidan R, Klipper E, Gilboa T et al. Endothelin-converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain. J Biol Chem 2005; 280: 40867-40874.
65. Khamaisi M, Keynan S, Bursztyn M et al. Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes. Nephron Physiol 2006; 102: p72-p80.
66. Terada Y, Moriyama T, Martin BM et al. RT-PCR microlocalization of mRNA for guanylyl cyclase-coupled ANF receptor in rat kidney. Am J Physiol 1991; 261(6 Part 2): F1080-F1087.
67. Sakurai T, Yanagisawa M, Takuwa Y et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990; 348: 732-735.